Serving Clients Nationwide.

Schedule A Consultation

602-900-8562

Boesen & Snow Law to Attend and Sponsor the NCPA Conference 2024, Promoting Proactive Audit Solutions for Independent Pharmacies

Scottsdale, AZ, October 20, 2024 Boesen & Snow Law, a leader in pharmacy law and PBM audit defense, is proud to announce its continued sponsorship and attendance at the National Community Pharmacists Association (NCPA) Annual Conference, taking place this year from October 26-29, 2024 in Columbus, Ohio. As a dedicated member of the NCPA, Boesen & Snow remains committed to supporting independent pharmacies with proactive audit solutions to safeguard their businesses against financial disruptions caused by Pharmacy Benefit Manager (PBM) audits.

At this year’s conference, Boesen & Snow will showcase its Proactive Audit Solutions, a comprehensive service designed to help pharmacies identify potential audit risks before PBMs initiate the process. With an industry-leading team of pharmacy law attorneys and audit experts, including former PBM auditors, Boesen & Snow provides services that mitigate financial exposure, protect operational continuity, and ensure compliance with PBM contracts.

“Independent pharmacies are vital to our healthcare system, and we’re excited to return to the NCPA Annual Conference to connect with pharmacy owners and managers,” said Mark Boesen, PharmD, JD, founding partner at Boesen & Snow. “By taking a proactive approach to audits, pharmacies can safeguard their future and remain financially strong. We’re here to provide the legal and operational guidance they need.”

Special Session: Proactive Audit Solutions and Tirzepatide Shortage Update As part of the conference agenda, Mark Boesen will present a session titled “Navigating PBM Audits and the Tirzepatide

Shortage: What Independent Pharmacies Need to Know.” Join us on Monday, October 28 from 2:00 – 2:30 PM in the Quick Consult Live Theater for an essential update on the ongoing tirzepatide shortage and how Boesen & Snow’s Proactive Audit Solutions can protect pharmacies from the financial and operational impacts of PBM audits. This session offers key insights on staying compliant, preparing for audits, and addressing supply challenges in today’s dynamic pharmacy landscape.

Key Features of Boesen & Snow’s Proactive Audit Solutions:
  • Audit Gap Analysis: Thoroughly assesses current practices to identify areas of
  • PBM Contract Compliance: Ensures operating procedures meet industry standards, reducing audit
  • Tailored SOPs and Staff Training: Customizes operational guidelines and prepares staff for audit readiness.
  • Mock Audits: Offers pharmacies the chance to experience a simulated PBM audit and address potential issues before the real

Why Choose Boesen & Snow?

Boesen & Snow’s team combines decades of pharmacy law experience with hands-on knowledge of PBM audits, led by Mark Boesen, PharmD, JD, and Mark Ziegler, PharmD, MBA, a former PBM audit leader at CVS Caremark. Their expertise equips pharmacies with the tools to stay compliant and financially secure in an ever-changing regulatory environment.

Visit Us at Booth #931 Pharmacies attending the NCPA Conference are encouraged to stop by the Boesen & Snow booth (#931) to learn more about their proactive audit services. Attendees can also schedule private consultations with the firm’s legal and pharmacy audit experts during the event.

About Boesen & Snow Law

Boesen & Snow Law specializes in pharmacy law and PBM audit defense, offering comprehensive legal representation and audit solutions for independent pharmacies nationwide. With a team of experienced attorneys and pharmacy professionals, the firm provides legal support that protects pharmacy operations and mitigates the financial impact of PBM audits.

Contact Information:

Boesen & Snow Law 8501 E. Princess Drive Suite 220
Scottsdale, AZ 85255
Phone: 602-900-8562
Email: [email protected]
Website: www.boesensnowlaw.com

Recent Posts

Categories
Archives

Schedule a Free Consultation

Fields marked with an * are required

  • This field is for validation purposes and should be left unchanged.